This article delves into the intricate challenges that the radiopharmaceutical sector faces and emphasizes the pivotal role of innovative automation solutions in overcoming obstacles.

The pharmaceutical industry has undergone a remarkable shift in the delivery route for pharmaceutical products, with injectable drugs taking center stage. According to the U.S. Food and Drug Administration (FDA), injectables now account for 40% of newly approved drugs, primarily administered via subcutaneous and intramuscular routes. This paradigm shift necessitates new strategies that prioritize patient-centric approaches to enhance treatment adherence.

EVEON is attending in various events this Spring 2023. Save the dates and come to meet us and discuss about your needs and how adaptive optics can improve your projects.

Cell and gene therapy delivery is an emergent and transformative industry. 

EVEON and Sensorion collaborating to develop an injection system for the delivery of gene therapy treatments into the inner ear

EVEON exhibited at Pharmapack - booth F68 and at Innovation Gallery, on February 1-2, 2023 in Paris (France). 

During the last years, drug delivery has evolved and new routes of administration have emerged.

Article OnDrugDelivery about the gap between patient safety and HealthCareWorkers for product preparation. And How safe and automatic, such as EVEON devices, can improve drug preparationCheckout our last article for multidose vials?

EVEON contributes to studies about feasibility of intratumoral delivery to induced glioblastoma, in a large animal model. EVEON developed the preclinical injection system for this project. Work on this subject has been published in the journal Plos One.

The project KinCellS, supported by the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, was launched on September 9th, 2020, with the consortium members : Nanobiose, project leader, EVEON and the SyMMES laboratory.